-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Names Sam Jackson Chief Medical Officer

PUBT·11/18/2026 12:15:27
Listen to the news
NervGen Names Sam Jackson Chief Medical Officer
  • NervGen appointed Sam Jackson chief medical officer.
  • Jackson most recently served as chief medical officer, neuroscience, at Aditum Bio, leading clinical development across its neuroscience portfolio.
  • He will lead the ongoing Phase 3 RESTORE study and support NVG-291's clinical expansion into additional indications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NervGen Pharma Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611180715PRIMZONEFULLFEED9879905) on November 18, 2026, and is solely responsible for the information contained therein.